CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Syndax Pharmaceuticals granted inducement stock options to purchase 162,100 shares to eight new employees under its 2023 Inducement Plan, with standard four-year vesting terms.

Importance:1/10
Sentiment:
0.00
inducement grantsequity compensationemployee retentionstock options
Related Companies

Read the original article

Published by GlobeNewswire Pharma on May 6, 2026 8:01 PM

Read Original